WinSanTor

Growth Stage

Ensuring no one suffers from Peripheral Neuropathy.

Analytics

Raised to Date: Raised: $596,649

Aggregate Commitments $

Platform

Wefunder

Start Date

09/28/2018

Close Date

03/20/2019

Min. Goal

$300,000

Max. Goal

$1,070,000

Min. Investment

$500

Security Type

SAFE

Funding Type

RegCF

Valuation Cap

$70,000,000

Discount Rate

0%

Rolling Commitments $

Status
Funded
Reporting Date

03/31/2019

Days Remaining
Funded
% of Min. Goal

199%

% of Max. Goal

56%

Likelihood of Max
Funded
Avg. Daily Raise

$3,449

Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Location

San Diego, California

Industry

Healthcare & Pharmaceuticals

Tech Sector

Winsantor is here to make sure that no one suffers from peripheral neuropathy (PN). PN affects 1 in 15 people in the US, and it’s when the nerves die due to disease, injuries, cancer, or genetic diseases. There is currently no treatment -- just drugs that help reduce the pain. Winsantor, however, is currently in trials that show they be on track to reverse the disease, both biologically and functionally. So far, over $30M of non-dilutive funding has driven R&D; they are currently entering Phase 2 of early efficacy studies; and they aim to have their drug approved by 2021 to start helping -- and changing -- the lives of those who are affected.
Create a free account today to gain access to KingsCrowd analytics.

Raise History

Offering Name Close Date Platform Valuation/Cap Total Raised Security Type Status Reg Type
WinSanTor 04/28/2020 StartEngine $75,000,000 $32,651 Convertible Note Funded RegCF
WinSanTor 03/20/2019 Wefunder $70,000,000 $596,649 SAFE Funded RegCF
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$12.42 /month
billed annually
Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings (excluding risk)
Advanced company search ( with ratings)
Markets page filters and historical industry data
Get Edge Annual

Edge Pro

$41.58 /month
billed annually
Full site access including KingsCrowd's qualitative analyst reports.
Plan Includes:
Everything in Edge, plus
Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
Search and filter based on Analyst Reports
In-depth risk ratings for every raise
Get Edge Pro Annual
Already a member? Log in here.

Create your first portfolio

Create your very own investment portfolio on KingsCrowd.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
WinSanTor on Wefunder
$
Platform: Wefunder
Security Type: SAFE
Valuation: $70,000,000
Invest in a different round for this company? Use my investment date to determine which raise I invested in.

Follow company

Follow WinSanTor on Wefunder
View on Wefunder (Closed)
Bullish / Bearish
You're Bullish on WinSanTor on Wefunder

Thank you for your vote on WinSanTor on Wefunder

Bullish / Bearish
You're Bearish on WinSanTor on Wefunder

Thank you for your vote on WinSanTor on Wefunder